Literature DB >> 28929586

Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.

.   

Abstract

Cancer is a major cause of illness in Australia and therefore ongoing monitoring of cancer in Australia is important. This study sources data from the Australian Institute of Health and Welfare (AIHW) and reports actual number of cases diagnosed and deaths, for all cancers combined and selected cancers, from 1982 to 2013 for incidence and from 1982 to 2014 for mortality, with projections to 2017 for both. It is estimated that 134 174 new cases of cancer (excluding basal and squamous cell carcinomas of the skin) will be diagnosed in 2017. The number of new cancer cases more than doubled from 47 414 in 1982. Prostate cancer is estimated to be the most commonly diagnosed cancer in males in 2017, whereas breast cancer is estimated to be the most commonly diagnosed cancer in females. It is estimated that there will be 47 753 deaths from cancer in Australia in 2017. Although the mortality rate decreased, the number of people who died in Australia from cancer almost doubled from 24 922 in 1982. Lung cancer was the most common cause of cancer death in both males and females. In 2011, cancer was the leading cause of disease burden in Australia.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Australia; burden of disease; early detection of cancer; incidence; mortality; neoplasm; screening

Mesh:

Year:  2017        PMID: 28929586     DOI: 10.1111/ajco.12761

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  10 in total

1.  Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review.

Authors:  Rezwanul Hasan Rana; Fariha Alam; Khorshed Alam; Jeff Gow
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-03       Impact factor: 4.553

2.  Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).

Authors:  Hiren Mandaliya; Mark Jones; Christopher Oldmeadow; Ina Ic Nordman
Journal:  Transl Lung Cancer Res       Date:  2019-12

3.  Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.

Authors:  Eleonora Feletto; Jie-Bin Lew; Joachim Worthington; Emily He; Michael Caruana; Katherine Butler; Harriet Hui; Natalie Taylor; Emily Banks; Karen Barclay; Kate Broun; Alison Butt; Rob Carter; Jeff Cuff; Anita Dessaix; Hooi Ee; Jon Emery; Ian M Frayling; Paul Grogan; Carol Holden; Christopher Horn; Mark A Jenkins; James G Kench; Maarit A Laaksonen; Barbara Leggett; Gillian Mitchell; Susan Morris; Bonny Parkinson; D James St John; Linda Taoube; Katherine Tucker; Melanie A Wakefield; Robyn L Ward; Aung Ko Win; Daniel L Worthley; Bruce K Armstrong; Finlay A Macrae; Karen Canfell
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

4.  Lifetime Costs of Surviving Cancer-A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study.

Authors:  Katharina M D Merollini; Louisa G Gordon; Joanne F Aitken; Michael G Kimlin
Journal:  Int J Environ Res Public Health       Date:  2020-04-20       Impact factor: 3.390

5.  The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.

Authors:  Patrick B Thomas; Inge Seim; Penny L Jeffery; Manuel D Gahete; Michelle Maugham; Gabrielle J Crisp; Andrew Stacey; Esha T Shah; Carina Walpole; Eliza J Whiteside; Colleen C Nelson; Adrian C Herington; Raúl M Luque; Rakesh N Veedu; Lisa K Chopin
Journal:  Int J Oncol       Date:  2019-10-04       Impact factor: 5.650

6.  Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma.

Authors:  Lei Dai; Xingchen Cai; Joseph Mugaanyi; Yelei Liu; Shuqi Mao; Changjiang Lu; Caide Lu
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

7.  Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model.

Authors:  Lei Dai; Joseph Mugaanyi; Xingchen Cai; Mingjun Dong; Caide Lu; Changjiang Lu
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

8.  Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis.

Authors:  Feng Wang; Limin Chen; Zhao Wang; Qiuyan Xu; He Huang; Hairong Wang; Xi Li; Mingjie Yu; Jiangen Chen; Fuhua Lin; Zhenghe Chen; Xiangheng Zhang; Qunying Yang; Yonggao Mou; Chengcheng Guo
Journal:  Cancer Cell Int       Date:  2022-10-14       Impact factor: 6.429

Review 9.  Targeting Apoptotic Pathways in Acute Myeloid Leukaemia.

Authors:  Jonathan R Sillar; Anoop K Enjeti
Journal:  Cancers (Basel)       Date:  2019-10-26       Impact factor: 6.639

10.  Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy.

Authors:  Alok Ranjan; Itishree Kaushik; Sanjay K Srivastava
Journal:  Cells       Date:  2020-09-22       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.